XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 33.34

-2.1%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: bob zagorin	3/16/2006 11:15:41 AM
	of 17367

XOMA makes Zacks "bull of the day" for 3/15/06. here's the summary... Xoma, Ltd. is a biopharmaceutical company that develops products to treat infectious diseases, immunological and inflammatory disorders, and cancer. The company’s lead product, Raptiva (for psoriasis), has hundred-million dollar potential given its favorable characteristics. Xoma should see improved business fundamentals over the next several quarters. The stock is up by 35% since we recommended it May 2005 and we believe that there is a further upside. Look look forward to several positive catalysts in 2006 to help keep the shares performing well. We see fair value at $2.50.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next